For the first time, researchers have discovered a single gene that simultaneously controls both the sourness and the colour of citrus fruit. 

Plants of the Panax genus—which includes ginseng and notoginseng—are known to suppress the growth of neighbouring plants through chemical warfare, but the precise molecular weapons and their targets have remained unclear. 

Grape aroma is shaped not only by the volatile compounds we can smell but also by their non‑volatile, sugar‑bound counterparts—flavour precursors locked away until fermentation releases them. 

For centuries, Epimedium has been used in traditional medicine to support bone health and vitality, yet the precise location of its active compounds within the plant—and the enzymes that create them—has remained a mystery. 

Fruit firmness is usually treated as a trait that is lost during ripening, but new evidence shows that part of the story begins much earlier, while the fruit is still building its structure. 

Patients with severe β-thalassemia face not only lifelong dependence on blood transfusions but also the management of serious and potentially life-threatening complications. The pathophysiology of this disorder is largely attributed to a defective transition from γ-globin to β-globin gene expression, a process essential for normal hemoglobin production after birth. This developmental transition involves the silencing of fetal γ-globin and coordinated activation of adult β-globin gene transcription. Central to this regulation are transcription factors that directly bind to the γ-globin promoter. This review synthesized recent advances in understanding the γ-to-β-globin switch, focusing on four principal transcription factors – GATA1, BCL11A, ZBTB7A, and NFY – and partner proteins including GATA2 and KLF1. In addition, we proposed a competitive binding model in which the GATA1/NFY and ZBTB7A/BCL11A protein complexes compete for promoter occupancy. This model provides a useful framework that may inform future strategies for the prevention, diagnosis, and treatment of β-thalassemia.

This study explored the link between cuproptosis, a type of cell death, and unexplained infertility (UI) using gene expression data. Researchers analyzed 27 cuproptosis-related genes in endometrial samples from UI patients, identifying two molecular clusters linked to immune cell infiltration. They tested seven machine learning models to predict UI, finding the support vector machine (SVM) model most effective, with high accuracy (AUC 0.918). The study suggests five cuproptosis-related genes could be potential biomarkers for UI, offering insights into the disease's molecular basis and aiding in future diagnostic and treatment strategies.

Glioblastoma (GBM) remains the most aggressive and lethal primary brain tumor, with a dismal prognosis despite decades of intensive research. While immunotherapy has revolutionized treatment for many cancers, GBM has proven remarkably refractory to immune-based interventions due to the absence of effective immunotherapeutic targets and the profoundly immunosuppressive tumor microenvironment. In this groundbreaking study, researchers employed CRISPR screening to systematically identify novel drivers of GBM progression, uncovering Niemann-Pick C1-like 1 (NPC1L1) as a previously unrecognized key regulator of GBM pathogenesis. Mechanistically, NPC1L1 modulates cholesterol metabolism to concurrently enhance tumor cell stemness and suppress CD8+ T-cell activation, creating a dual mechanism that drives tumor progression while evading immune surveillance. Most notably, combined treatment with ezetimibe, an FDA-approved NPC1L1 inhibitor, and anti-PD-1 antibody elicited potent antitumor activity in GBM orthotopic mouse models, offering a promising translational strategy. These findings establish NPC1L1 as a critical regulator of GBM pathogenesis and underscore the therapeutic potential of targeting NPC1L1-mediated cholesterol metabolism for developing novel GBM immunotherapies, opening new avenues for treating this devastating disease.